Hot Features
Premium
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Zeitraum:
Zeichenmodus:
| Volumen | 18.250 |
|
|||||
| News | - | ||||||
| Tageshoch | 15,91 | Niedrig Hoch |
|||||
| Tagestief | 15,45 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Gyre Therapeutics Inc | GYRE | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,08 | -0,51% | 15,55 | 19:05:34 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 15,45 | 15,45 | 15,91 | 15,63 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 373 | 18.250 | US$ 15,65 | US$ 285.547 | - | 5,88 - 30,40 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 19:08:47 | 1 | US$ 15,50 | USD |
Finanzwerte GYRE
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 39,5M | 2,53M | - | 113,45M | -92,93M | -36,71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Gyre Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 13.5.2024 | 22:07 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09.5.2024 | 22:10 | GlobeNewswire Inc. | Gyre Therapeutics Reports First Quarter 2024 Financial.. |
| 09.5.2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08.5.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 26.3.2024 | 11:00 | GlobeNewswire Inc. | Gyre Therapeutics Reports Full Year 2023 Financial Results.. |
| 21.3.2024 | 12:00 | GlobeNewswire Inc. | Gyre Therapeutics Expands Board of Directors with.. |
| 15.12.2023 | 15:04 | PR Newswire (US) | Totus Medicines Announces Appointment of Nassim Usman,.. |
| 13.11.2023 | 13:00 | GlobeNewswire Inc. | Gyre Therapeutics Presents Poster at the American.. |
| 02.11.2023 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01.11.2023 | 22:18 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 01.11.2023 | 21:58 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
Forum Gyre Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
GYRE Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 15,40 | 15,99 | 14,52 | 15,48 | 48.032 | 0,15 | 0,97% |
| 1 Monat | 15,51 | 17,25 | 13,50 | 15,59 | 62.878 | 0,04 | 0,26% |
| 3 Monate | 14,36 | 26,37 | 13,3241 | 17,67 | 70.263 | 1,19 | 8,29% |
| 6 Monate | 12,60 | 30,40 | 10,41 | 18,90 | 97.769 | 2,95 | 23,41% |
| 1 Jahr | 7,00 | 30,40 | 5,88 | 18,50 | 92.794 | 8,55 | 122,14% |
| 3 Jahre | 7,00 | 30,40 | 5,88 | 18,50 | 92.794 | 8,55 | 122,14% |
| 5 Jahre | 7,00 | 30,40 | 5,88 | 18,50 | 92.794 | 8,55 | 122,14% |
